Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Net: 2023-2024

Historic Receivables - Net for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $10.6 million.

  • Zhengye Biotechnology Holding's Receivables - Net was N/A to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $10.6 million for FY2024, which is 18.97% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Receivables - Net of $10.6 million as of FY2024, which was down 18.97% from $13.1 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Receivables - Net high stood at $13.1 million for FY2023, and its period low was $10.6 million during FY2024.
  • Over the past 2 years, Zhengye Biotechnology Holding's median Receivables - Net value was $11.9 million (recorded in 2023), while the average stood at $11.9 million.
  • Data for Zhengye Biotechnology Holding's Receivables - Net shows a maximum YoY declined of 18.97% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Receivables - Net (Yearly) stood at $13.1 million in 2023, then decreased by 18.97% to $10.6 million in 2024.